Cargando…
Abnormal Dexamethasone Suppression Tests in a Rifapentine-Treated Patient With Primary Aldosteronism
Aldosterone-producing adenoma (APA) is a main cause of primary aldosteronism (PA). Given that a large benign-appearing unilateral masse (>1 cm in diameter) may represent an aldosterone and cortisol-co-secreting adenoma, dexamethasone suppression testing is required in such patients to exclude or...
Autores principales: | Wang, Hongman, Song, Ying, Xu, Zhixin, Jing, Ying, He, Wenwen, Feng, Zhengping, Li, Qifu, Yang, Shumin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7499122/ https://www.ncbi.nlm.nih.gov/pubmed/33013693 http://dx.doi.org/10.3389/fendo.2020.00593 |
Ejemplares similares
-
MON-221 Seated Saline Suppression Testing Is Comparable to Captopril Challenge Test for the Diagnosis of Primary Aldosteronism: A Prospective Study
por: Hu, Jinbo, et al.
Publicado: (2020) -
Elevated Myoglobin in Patients With Primary Aldosteronism: A Cross-Sectional Study
por: Kang, Bing, et al.
Publicado: (2022) -
Cardiovascular events and all-cause mortality in surgically or medically treated primary aldosteronism: A Meta-analysis
por: Jing, Ying, et al.
Publicado: (2021) -
Aldosterone/direct renin concentration ratio as a screening test for primary aldosteronism: A meta-analysis
por: Li, Xiyue, et al.
Publicado: (2016) -
Preoperative Renin Status Indicate the Clinical Outcome of Aldosterone-Producing Adenoma
por: Xu, Felicity, et al.
Publicado: (2021)